Healthequity (HQY) Cash from Investing Activities (2013 - 2026)

Healthequity's Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$13.9 million for Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 13.87% year-over-year to -$13.9 million in Q2 2026; TTM through Apr 2026 was -$44.9 million, a 82.16% increase from a year earlier, with the FY2026 full-year figure at -$47.1 million, up 90.67% from the prior year.
• Cash from Investing Activities slipped to -$13.9 million in Q2 2026 per HQY's latest filing, from -$8.4 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$8.4 million in Q1 2026 and bottomed at -$471.3 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$13.5 million (2022), against an average of -$66.8 million.
• Across the five-year window, Cash from Investing Activities surged 97.82% in 2023 and slumped 2855.12% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$13.5 million in 2022, then slipped by 13.99% to -$15.4 million in 2023, then gained by 16.57% to -$12.9 million in 2024, then grew by 11.54% to -$11.4 million in 2025, then retreated by 22.17% to -$13.9 million in 2026.
• Per Business Quant, the three latest HQY Cash from Investing Activities figures stand at -$13.9 million (Q2 2026), -$8.4 million (Q1 2026), and -$11.4 million (Q4 2025).